Medications for Infant Respiratory Distress Syndrome

These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Infant Respiratory Distress Syndrome.

Found 1 Approved Drug for Infant Respiratory Distress Syndrome

Survanta

Generic Name
Beractant

Survanta

Generic Name
Beractant
Form: Suspension
Method of administration: Endotracheal
FDA approval date: July 01, 1991
SURVANTA is indicated for prevention and treatment (“rescue”) of Respiratory Distress Syndrome (RDS) (hyaline membrane disease) in premature infants.
Showing 1-1 of 1
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances